Showing 311-320 of 353 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| microRNA-146a is a potential therapeutic target for type 1 diabetes | Case Western Reserve University | Parameswaran Ramakrishnan | Cures | 01-June-2024 to 31-May-2027 | $600,000.00 |
| Novel mechanism and method to control T cell mediated autoimmunity in type 1 diabetes | Case Western Reserve University | Parameswaran Ramakrishnan | Cures | 01-June-2022 to 31-May-2027 | $600,000.00 |
| Pro-Angiogenic and Immune-Modulatory Scaffolds for the Functional Engraftment of Islets in the Subcutaneous Space | Carnegie Mellon University | Adam Feinberg | Cures | 01-November-2024 to 31-October-2027 | $950,000.00 |
| Local bioelectronic oxygenation for islet engraftment | Carnegie Mellon University | Tzahi Cohen-Karni | Cures | 01-August-2024 to 31-July-2027 | $974,998.74 |
| Cellular Sentinels of Islet Transplant Rejection | California Institute of Technology | Mikhail Shapiro | Cures | 01-July-2023 to 30-June-2027 | $750,000.00 |
| Moving Biomimetic Scaffolds + Islet Cell Therapy Towards Pre-IND and IND Readiness | Brown University | Tejal Desai | Cures | 01-September-2026 to 31-August-2029 | $1,379,931.48 |
| Digital Health Model to Support Adoption of CKM By Underserved Adults with T1D: Evaluation of User Experience and Treatment Guidance | Boston Medical Center | Howard Wolpert | Improving Lives | 01-September-2026 to 31-August-2029 | $1,444,533.25 |
| Harnessing Neonatal Regulatory T Cells for Precision Immunotherapy in Type 1 Diabetes | Boston Children’s Hospital | Ayano Kohlgruber | Cures | 01-March-2026 to 28-February-2031 | $998,713.47 |
| Engineering fully vascularized SC-islets through endothelial integration and endocrine-vascular crosstalk | Boston Children’s Hospital | Juan Melero-Martin | Cures | 01-November-2025 to 31-October-2027 | $599,994.46 |
| Engineered Nanobodies to Visualize and Direct Antigen-Specific Tolerance in T1D | Boston Children’s Hospital | Novalia Pishesha | Cures | 01-March-2025 to 28-February-2030 | $999,999.00 |